James Hardie Industries plc (JHX) Q1 2027 Earnings Call Transcript

SA Transcripts 161.61K Followers Follow James Hardie Industries plc ( JHX ) Q1 2027 Earnings Call August 6, 2026 6:00 PM EDT Company Participants Bill Seymour - Vice President of Investor Relations Aaron Erter - CEO & Executive Director Ryan Lada - Chief Financial Officer Jonathan Skelly - President & GM of James Hardie North America ( NA ) Building Products Group Conference Call Participants Ryan Merkel - William Blair & Company L.L.C., Research Division Brook Campbell-Crawford - Barrenjoey Markets Pty Limited, Research Division Keith Hughes - Truist Securities, Inc., Research Division Keith Chau - MST Financial Services Pty Limited, Research Division Philip Ng - Jefferies LLC, Research Division Peter Steyn - Macquarie Research Timothy Wojs - Robert W. Baird & Co. Incorporated, Research Division Harry Saunders - E&P, Research Division Matthew Bouley - Barclays Bank PLC, Research Division Daniel Sykes - Jarden Limited, Research Division Rafe Jadrosich - BofA Securities, Research Division Presentation Operator Welcome to the James Hardie Fiscal First Quarter 2027 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Bill Seymour, VP of Investor Relations. Please go ahead. Bill Seymour Vice President of Investor Relations Thank you, operator, and thank you to everyone for joining today's call. I'm joined today by Aaron Erter, CEO of James Hardie; Ryan Lada, CFO of James Hardie; and Jon Skelly, President and General Manager of James Hardie, North America Building Products. Before we begin the call, please note that during prepared remarks and Q&A, we may refer to non-GAAP financial measures and make forward-looking statements. You can refer to several related cautionary and other notes on Slide 2 of our earnings presentation for more information. Forward-looking statements made during today's conference call and in the earnings materials speak only as of the date of this presentation. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements.